Inactivation of Trypanosoma cruzi trypomastigote forms in blood components with a Psoralen and Ultraviolet A light.
Inactivation of Trypanosoma cruzi trypomastigote forms in blood components with a Psoralen and Ultraviolet A light.
复制标题
用补骨脂素和紫外线 A 光灭活血液成分中的克氏锥虫锥鞭毛体。
DOI:
10.1111/j.1751-1097.1996.tb05656.x
复制
发表时间:
1996
影响因子:
3.3
通讯作者:
Ben-Hur,E
中科院分区:
文献类型:
--
作者:
Gottlieb,P;Margolis-Nunno,H;Robinson,R;Shen,LG;Chimezie,E;Horowitz,B;Ben-Hur,E
Inactivation of the blood‐borne parasiteTrypanosoma cruziby UVA and 4′‐aminomethyl‐4,5′,8‐trimethylpsor‐alen (AMT) was studied in the blood components fresh frozen plasma (FFP) and platelet concentrate (PC). The AMT was utilized at a concentration of 50 μg/mL and the inactivation procedure included the flavonoid rutin (at 0.35 mM), a quencher of type I and type II photo‐reactants, which we have previously found to maintain platelet integrity during this treatment regimen. Within both FFP and PC, complete inactivation of the infective form ofT. cruzi, the trypomastigote, was achieved at a UVA (320–400 nm radiation) fluence of 4.2 J/cm2. We note that while the infectivity of the parasite is eliminated at 4.2 J/cmZthe trypomastigote motility continues for at least 16 h post‐treatment and is inhibited only after much higher light doses. Isolation of total DNA from the parasite cells after treatment in the presence of3H‐AMT indicated that at the lethal UVA fluence about 0.5 AMT adducts per kilobase pairs occurred. These results suggest that this psoralen plus UVA methodology, which shows promise in enhancing the viral safety of PC, may in addition eliminate bloodborneT. cruzi, the causative agent of Chagas disease.